Cargando…
Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study
BACKGROUND: Uterine fibroids are the most common benign neoplasm of the uterus and a major source of morbidity for women. We report an overview of trends in uterine fibroids of incidence rate, prevalence rate, years lived with disability (YLDs) rate in 204 countries and territories over the past 30...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199532/ https://www.ncbi.nlm.nih.gov/pubmed/37208621 http://dx.doi.org/10.1186/s12889-023-15765-x |
_version_ | 1785044953801424896 |
---|---|
author | Lou, Zheng Huang, Yizhou Li, Shuting Luo, Zhou Li, Chunming Chu, Ketan Zhang, Tao Song, Peige Zhou, Jianhong |
author_facet | Lou, Zheng Huang, Yizhou Li, Shuting Luo, Zhou Li, Chunming Chu, Ketan Zhang, Tao Song, Peige Zhou, Jianhong |
author_sort | Lou, Zheng |
collection | PubMed |
description | BACKGROUND: Uterine fibroids are the most common benign neoplasm of the uterus and a major source of morbidity for women. We report an overview of trends in uterine fibroids of incidence rate, prevalence rate, years lived with disability (YLDs) rate in 204 countries and territories over the past 30 years and associations with age, period, and birth cohort. METHODS: The incident case, incidence rate, age-standardized rate (ASR) for incidence, prevalent case, prevalence rate, ASR for prevalence, number of YLDs, YLD rate, and ASR for YLDs were derived from the Global Burden of Disease 2019 (GBD 2019) study. We utilized an age-period-cohort (APC) model to estimate overall annual percentage changes in the rate of incidence, prevalence, and YLDs (net drifts), annual percentage changes from 10 to 14 years to 65–69 years (local drifts), period and cohort relative risks (period/cohort effects) between 1990 and 2019. RESULTS: Globally, the incident cases, prevalent cases, and the number of YLDs of uterine fibroids increased from 1990 to 2019 with the growth of 67.07%, 78.82% and 77.34%, respectively. High Socio-demographic Index (SDI) and high-middle SDI quintiles with decreasing trends (net drift < 0.0%), and increasing trends (net drift > 0.0%) were observed in middle SDI, low-middle SDI, and low SDI quintiles in annual percentage change of incidence rate, prevalence rate and YLDs rate over the past 30 years. There were 186 countries and territories that showed an increasing trend in incidence rate, 183 showed an increasing trend in prevalence rate and 174 showed an increasing trend in YLDs rate. Moreover, the effects of age on uterine fibroids increased with age and peaked at 35–44 years and then declined with advancing age. Both the period and cohort effects on uterine fibroids showed increasing trend in middle SDI, low-middle SDI and low SDI quintiles in recent 15 years and birth cohort later than 1965. CONCLUSIONS: The global burden of uterine fibroids is becoming more serious in middle SDI, low-middle SDI and low SDI quintiles. Raising awareness of uterine fibroids, increasing medical investment and improving levels of medical care are necessary to reduce future burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15765-x. |
format | Online Article Text |
id | pubmed-10199532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101995322023-05-21 Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study Lou, Zheng Huang, Yizhou Li, Shuting Luo, Zhou Li, Chunming Chu, Ketan Zhang, Tao Song, Peige Zhou, Jianhong BMC Public Health Research BACKGROUND: Uterine fibroids are the most common benign neoplasm of the uterus and a major source of morbidity for women. We report an overview of trends in uterine fibroids of incidence rate, prevalence rate, years lived with disability (YLDs) rate in 204 countries and territories over the past 30 years and associations with age, period, and birth cohort. METHODS: The incident case, incidence rate, age-standardized rate (ASR) for incidence, prevalent case, prevalence rate, ASR for prevalence, number of YLDs, YLD rate, and ASR for YLDs were derived from the Global Burden of Disease 2019 (GBD 2019) study. We utilized an age-period-cohort (APC) model to estimate overall annual percentage changes in the rate of incidence, prevalence, and YLDs (net drifts), annual percentage changes from 10 to 14 years to 65–69 years (local drifts), period and cohort relative risks (period/cohort effects) between 1990 and 2019. RESULTS: Globally, the incident cases, prevalent cases, and the number of YLDs of uterine fibroids increased from 1990 to 2019 with the growth of 67.07%, 78.82% and 77.34%, respectively. High Socio-demographic Index (SDI) and high-middle SDI quintiles with decreasing trends (net drift < 0.0%), and increasing trends (net drift > 0.0%) were observed in middle SDI, low-middle SDI, and low SDI quintiles in annual percentage change of incidence rate, prevalence rate and YLDs rate over the past 30 years. There were 186 countries and territories that showed an increasing trend in incidence rate, 183 showed an increasing trend in prevalence rate and 174 showed an increasing trend in YLDs rate. Moreover, the effects of age on uterine fibroids increased with age and peaked at 35–44 years and then declined with advancing age. Both the period and cohort effects on uterine fibroids showed increasing trend in middle SDI, low-middle SDI and low SDI quintiles in recent 15 years and birth cohort later than 1965. CONCLUSIONS: The global burden of uterine fibroids is becoming more serious in middle SDI, low-middle SDI and low SDI quintiles. Raising awareness of uterine fibroids, increasing medical investment and improving levels of medical care are necessary to reduce future burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15765-x. BioMed Central 2023-05-19 /pmc/articles/PMC10199532/ /pubmed/37208621 http://dx.doi.org/10.1186/s12889-023-15765-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lou, Zheng Huang, Yizhou Li, Shuting Luo, Zhou Li, Chunming Chu, Ketan Zhang, Tao Song, Peige Zhou, Jianhong Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title | Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title_full | Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title_fullStr | Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title_full_unstemmed | Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title_short | Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
title_sort | global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199532/ https://www.ncbi.nlm.nih.gov/pubmed/37208621 http://dx.doi.org/10.1186/s12889-023-15765-x |
work_keys_str_mv | AT louzheng globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT huangyizhou globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT lishuting globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT luozhou globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT lichunming globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT chuketan globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT zhangtao globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT songpeige globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study AT zhoujianhong globalregionalandnationaltimetrendsinincidenceprevalenceyearslivedwithdisabilityforuterinefibroids19902019anageperiodcohortanalysisfortheglobalburdenofdisease2019study |